JP2017057194A - Allergen-reducing and antimicrobial composition - Google Patents
Allergen-reducing and antimicrobial composition Download PDFInfo
- Publication number
- JP2017057194A JP2017057194A JP2016163991A JP2016163991A JP2017057194A JP 2017057194 A JP2017057194 A JP 2017057194A JP 2016163991 A JP2016163991 A JP 2016163991A JP 2016163991 A JP2016163991 A JP 2016163991A JP 2017057194 A JP2017057194 A JP 2017057194A
- Authority
- JP
- Japan
- Prior art keywords
- allergen
- reducing
- salts
- salt
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 6
- 239000013566 allergen Substances 0.000 claims abstract description 46
- -1 rare earth salt Chemical class 0.000 claims abstract description 36
- 229910052761 rare earth metal Inorganic materials 0.000 claims abstract description 17
- 125000002091 cationic group Chemical group 0.000 claims abstract description 16
- 230000000844 anti-bacterial effect Effects 0.000 claims description 28
- 239000003242 anti bacterial agent Substances 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 12
- 239000011701 zinc Substances 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 229920002413 Polyhexanide Chemical group 0.000 claims description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 150000000703 Cerium Chemical class 0.000 claims description 5
- 150000002603 lanthanum Chemical class 0.000 claims description 5
- 150000000921 Gadolinium Chemical class 0.000 claims description 4
- 150000001225 Ytterbium Chemical class 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 3
- FGDLGJWCMASAHH-UHFFFAOYSA-N butane;dihydrobromide Chemical compound Br.Br.CCCC FGDLGJWCMASAHH-UHFFFAOYSA-N 0.000 claims description 3
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims description 3
- 229960000306 zinc gluconate Drugs 0.000 claims description 3
- 239000011670 zinc gluconate Substances 0.000 claims description 3
- 235000011478 zinc gluconate Nutrition 0.000 claims description 3
- 150000001216 Samarium Chemical class 0.000 claims description 2
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 claims description 2
- 241000238876 Acari Species 0.000 abstract description 15
- 150000001261 hydroxy acids Chemical class 0.000 abstract description 13
- 241000894006 Bacteria Species 0.000 abstract description 11
- 150000003751 zinc Chemical class 0.000 abstract description 7
- 239000013573 pollen allergen Substances 0.000 abstract description 5
- 208000001840 Dandruff Diseases 0.000 abstract description 3
- 238000004040 coloring Methods 0.000 abstract description 2
- 239000004599 antimicrobial Substances 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 2
- 241000282326 Felis catus Species 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 241000218645 Cedrus Species 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 8
- 230000001603 reducing effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 229920001213 Polysorbate 20 Polymers 0.000 description 5
- 244000052616 bacterial pathogen Species 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000174 gluconic acid Substances 0.000 description 4
- 235000012208 gluconic acid Nutrition 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Chemical group CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000238713 Dermatophagoides farinae Species 0.000 description 3
- 241000238740 Dermatophagoides pteronyssinus Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 241000282373 Panthera pardus Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 150000003841 chloride salts Chemical class 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- IBHWREHFNDMRPR-UHFFFAOYSA-N 2,4,6-Trihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=C(O)C=C1O IBHWREHFNDMRPR-UHFFFAOYSA-N 0.000 description 2
- OMGKKRHVRFEREE-UHFFFAOYSA-K 2-hydroxypropanoate;lanthanum(3+) Chemical compound [La+3].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O OMGKKRHVRFEREE-UHFFFAOYSA-K 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- 244000036975 Ambrosia artemisiifolia Species 0.000 description 2
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 240000005109 Cryptomeria japonica Species 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000000895 acaricidal effect Effects 0.000 description 2
- 239000000642 acaricide Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 235000003484 annual ragweed Nutrition 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 235000006263 bur ragweed Nutrition 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000003488 common ragweed Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 235000009736 ragweed Nutrition 0.000 description 2
- 229910001404 rare earth metal oxide Inorganic materials 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- SBNFWQZLDJGRLK-RTWAWAEBSA-N (1R)-trans-phenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-RTWAWAEBSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 1
- OTOIIPJYVQJATP-BYPYZUCNSA-N (R)-pantoic acid Chemical compound OCC(C)(C)[C@@H](O)C(O)=O OTOIIPJYVQJATP-BYPYZUCNSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- AFENDNXGAFYKQO-VKHMYHEASA-N (S)-2-hydroxybutyric acid Chemical compound CC[C@H](O)C(O)=O AFENDNXGAFYKQO-VKHMYHEASA-N 0.000 description 1
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- GTOFKXZQQDSVFH-UHFFFAOYSA-N 2-benzylsuccinic acid Chemical compound OC(=O)CC(C(O)=O)CC1=CC=CC=C1 GTOFKXZQQDSVFH-UHFFFAOYSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- XFTRTWQBIOMVPK-YFKPBYRVSA-N Citramalic acid Natural products OC(=O)[C@](O)(C)CC(O)=O XFTRTWQBIOMVPK-YFKPBYRVSA-N 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 108010055622 Dermatophagoides farinae antigen f 1 Proteins 0.000 description 1
- 150000000914 Dysprosium Chemical class 0.000 description 1
- 150000000917 Erbium Chemical class 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 150000000918 Europium Chemical class 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005661 Hexythiazox Substances 0.000 description 1
- 150000000922 Holmium Chemical class 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 150000001169 Lutetium Chemical class 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 150000001206 Neodymium Chemical class 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 150000001213 Praseodymium Chemical class 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 description 1
- 239000005663 Pyridaben Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 101100084176 Staphylococcus aureus pre gene Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 150000001217 Terbium Chemical class 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229910052775 Thulium Inorganic materials 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000013556 antirust agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 150000004283 biguanides Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 244000213578 camo Species 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- XFTRTWQBIOMVPK-UHFFFAOYSA-N citramalic acid Chemical compound OC(=O)C(O)(C)CC(O)=O XFTRTWQBIOMVPK-UHFFFAOYSA-N 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000001224 daucus carota l. seed absolute Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- UOAMTSKGCBMZTC-UHFFFAOYSA-N dicofol Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)(Cl)Cl)(O)C1=CC=C(Cl)C=C1 UOAMTSKGCBMZTC-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000005165 hydroxybenzoic acids Chemical class 0.000 description 1
- 239000001735 hyssopus officinalis l. herb oil Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- KBHDSWIXRODKSZ-UHFFFAOYSA-N methyl 5-chloro-2-(trifluoromethylsulfonylamino)benzoate Chemical compound COC(=O)C1=CC(Cl)=CC=C1NS(=O)(=O)C(F)(F)F KBHDSWIXRODKSZ-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- 229920006173 natural rubber latex Polymers 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000002903 organophosphorus compounds Chemical class 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- 229960003536 phenothrin Drugs 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229960002796 polystyrene sulfonate Drugs 0.000 description 1
- 239000011970 polystyrene sulfonate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 1
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000002455 scale inhibitor Substances 0.000 description 1
- 150000003325 scandium Chemical class 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- FDFPDGIMPRFRJP-UHFFFAOYSA-K trichlorolanthanum;heptahydrate Chemical compound O.O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[La+3] FDFPDGIMPRFRJP-UHFFFAOYSA-K 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 150000003746 yttrium Chemical class 0.000 description 1
- 229940021724 zinc gluconate trihydrate Drugs 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
本発明は、液体のアレルゲン低減化および抗菌組成物に関する。さらには、室内等に存在するダニや花粉等のアレルゲンの低減化と、雑菌の繁殖を抑制するためのアレルゲン低減化および抗菌組成物に関する。 The present invention relates to liquid allergen reducing and antimicrobial compositions. Furthermore, the present invention relates to a reduction in allergens such as mites and pollen existing indoors, an allergen reduction and antibacterial composition for suppressing the propagation of various bacteria.
喘息やアトピー性皮膚炎、アレルギー性鼻炎等のアレルギー性疾患は多くの人が悩まされているものであり、特に近年では増加する傾向となっている。これらのアレルギー性疾患の原因となっているのは環境中に存在する種々のアレルゲンであり、それらの中でも屋内に棲息するダニやペットの毛、花粉、カビは代表的な吸入性のアレルゲンとして、良く知られている。特に家屋内に生息する塵性ダニであるヒョウヒダニ類はアレルゲンの発生源として大きな問題となっている。ヒョウヒダニ類は畳、絨毯、寝具、カーテン等の家屋内の繊維製品、あるいは屋外においても電車や自動車等の移動車両の座席シート生地等が生育の温床となる。 Allergic diseases such as asthma, atopic dermatitis, and allergic rhinitis are plagued by many people, and in recent years, the tendency has been increasing. The causes of these allergic diseases are various allergens present in the environment. Among them, mites, pet hair, pollen, and mold that inhabit indoors are typical inhalable allergens. Well known. In particular, leopard mites, which are dust mites that live in the house, are a major problem as a source of allergens. Leopard mites are a hotbed for growing textile products in the house such as tatami mats, carpets, bedding, curtains, etc., or seat sheet fabrics of moving vehicles such as trains and cars outdoors.
ヒョウヒダニ類の中でも、コナヒョウヒダニ(Dermatophagoides farinae)とヤケヒョウヒダニ(Dermatophagoides pteronyssinus)は代表的な種であり、これらのダニの死骸や糞が強いアレルゲン物質となる。また春先に飛散するスギ(Cryptomeria japonica)の花粉を初め、多種の植物の花粉もアレルゲンとなるものであり、特にアレルギー性鼻炎を発症させる原因となっている。飛散する花粉は春先のスギ花粉だけでなく、ヒノキ、ヨモギ、ブタクサ、カモガヤ等、多くの種類があり一年を通じて何らかの花粉が飛散している状態であり、いつの時期でも花粉によるアレルギーを引き起こす危険性があると考えられる。 Among the leopard mites, Dermatophagoides farinae and Dermatophagoides pteronyssinus are typical species, and the dead bodies and feces of these mites are strong allergen substances. In addition, pollen of various plants including cedar ( Cryptomeria japonica ) pollen scattered in early spring is also an allergen, and causes allergic rhinitis in particular. The pollen that scatters is not only cedar pollen in the early spring, but also many kinds of cypress, mugwort, ragweed, camo, etc. There is a state that some kind of pollen is scattered throughout the year, and there is a risk of causing pollen allergies at any time It is thought that there is.
住環境において、特に台所、洗面所、トイレ、浴室等の、水回りの生活空間においては雑菌の繁殖が起こりやすく、不快な臭気を発生させる原因となっている。このような臭気の発生を抑制するためには、雑菌の繁殖を抑えることが重要であり、消臭剤によって一時的に軽減させることはできても根本的な解決にはならなかった。雑菌の繁殖を抑制するためには、種々の抗菌組成物が提案されており、無機系抗菌剤として抗菌性金属塩や、有機系抗菌剤として緑茶成分のような天然成分、四級アンモニウム塩等のようなカチオン系抗菌剤が用いられている(特許文献1〜4)。最近では雑菌の繁殖抑制による消臭に加えて、ダニや花粉等のアレルゲンの低減化も同時に行えるような剤が要望されている。 In living environments, especially in living spaces around water, such as kitchens, washrooms, toilets, and bathrooms, it is easy for bacteria to propagate, causing unpleasant odors. In order to suppress the generation of such an odor, it is important to suppress the propagation of various germs, and even if it can be temporarily reduced by a deodorant, it has not been a fundamental solution. Various antibacterial compositions have been proposed in order to suppress the growth of various germs. Antibacterial metal salts as inorganic antibacterial agents, natural ingredients such as green tea ingredients as organic antibacterial agents, quaternary ammonium salts, etc. Such cationic antibacterial agents are used (Patent Documents 1 to 4). Recently, in addition to deodorization by suppressing the growth of various bacteria, an agent that can simultaneously reduce allergens such as mites and pollen has been demanded.
ダニやスギ花粉等の住環境に存在するアレルゲンを低減化させ、さらに処理した部分の雑菌の繁殖を抑制することができるアレルゲン低減化および抗菌組成物を提供することが本発明の課題である。 It is an object of the present invention to provide an allergen-reducing and antibacterial composition capable of reducing allergens present in the living environment such as mites and cedar pollen and further suppressing the propagation of various germs in the treated part.
本発明者らは、このような課題を解決するため鋭意研究を行った結果、ヒドロキシ酸の亜鉛塩とカチオン性抗菌剤を含有する組成物、さらにはヒドロキシ酸の亜鉛塩、希土類塩とカチオン性抗菌剤を含有する組成物が効率的に住環境に存在するアレルゲンを低減し、雑菌の繁殖を抑制することができることを見出し、本発明を完成させた。 As a result of intensive studies to solve such problems, the present inventors have found that a composition containing a zinc salt of a hydroxy acid and a cationic antibacterial agent, as well as a zinc salt of a hydroxy acid, a rare earth salt and a cationic property The present inventors have found that a composition containing an antibacterial agent can efficiently reduce allergens present in the living environment and suppress the propagation of various germs, thereby completing the present invention.
すなわち本発明は、(1)ヒドロキシ酸亜鉛およびカチオン性抗菌剤を含有するアレルゲン低減化および抗菌組成物であり、(2)ヒドロキシ酸亜鉛、希土類塩およびカチオン性抗菌剤を含有するアレルゲン低減化および抗菌組成物であり、(3)希土類塩がランタン塩、セリウム塩、ガドリニウム塩およびイッテルビウム塩から選択される一種以上の塩である上記に挙げたアレルゲン低減化および抗菌組成物であり、(4)ヒドロキシ酸亜鉛がグルコン酸亜鉛であり、カチオン性抗菌剤がビス4級ピリジニウム塩およびポリヘキサメチレンビグアナイドから選択される少なくとも一種類である、(1)〜(3)に挙げたアレルゲン低減化および抗菌組成物であり、(5)ビス4級ピリジニウム塩が、1,4−ビス(3,3’−(1−デシルピリジニウム)メチルオキシ)ブタンジブロミドである、(1)〜(4)に挙げたアレルゲン低減化および抗菌組成物であり、(6)使用用途が噴霧用であることを特徴とする、(1)〜(5)に挙げた記載のアレルゲン低減化および抗菌組成物。 That is, the present invention is (1) an allergen reducing and antibacterial composition containing zinc hydroxy acid and a cationic antibacterial agent, and (2) an allergen reducing and antibacterial agent containing zinc hydroxy acid, a rare earth salt and a cationic antibacterial agent. (3) the allergen-reducing and antibacterial composition listed above, wherein the rare earth salt is one or more salts selected from lanthanum salts, cerium salts, gadolinium salts and ytterbium salts, (4) Allergen-reducing and antibacterial listed in (1) to (3), wherein the hydroxy hydroxy zinc is zinc gluconate and the cationic antibacterial agent is at least one selected from bis quaternary pyridinium salts and polyhexamethylene biguanides (5) Bis quaternary pyridinium salt is 1,4-bis (3,3 ′-(1-decyl) (1) The allergen-reducing and antibacterial composition listed in (1) to (4), which is lysium) methyloxy) butanedibromide, and (6) characterized in that the intended use is for spraying. The allergen-reducing and antibacterial composition described in (5).
本発明のアレルゲン低減化および抗菌組成物を用いて、環境中、例えば室内の床や壁等、室内にあるカーペット、ソファー、壁紙、カーテン等のインテリア類、布団側地、布団カバー、布団中綿、シーツ、枕カバー、マット等の寝具類、カーシート、カーマット等の自動車部品類、ぬいぐるみ等に噴霧、塗布、加工あるいは上記物品から除去、払拭することが可能な組成物を提供することができる。上記物品から除去、払拭する場合には、本発明のアレルゲン低減化および抗菌組成物を紙、不織布または繊維等に加工し、ワイパー、タオル、シート等の形状にすることができる。 Using the allergen-reducing and antibacterial composition of the present invention, in the environment, for example, indoor floors and walls, interiors such as indoor carpets, sofas, wallpaper, curtains, duvet side, duvet covers, duvet batting, sheets Further, it is possible to provide a composition that can be sprayed, applied, processed, or removed and wiped from the article on bedding such as pillow covers and mats, automobile parts such as car seats and car mats, and stuffed animals. When removing and wiping from the article, the allergen-reducing and antibacterial composition of the present invention can be processed into paper, non-woven fabric, fiber, or the like to form a wiper, towel, sheet or the like.
本発明に使用する亜鉛塩はヒドロキシ酸の亜鉛塩であり、ヒドロキシ酸は、水酸基を一つあるいは二つ以上有するカルボン酸であり、具体的な例としては、グリコール酸、グリセリン酸、グルコン酸、グルクロン酸、乳酸、タルトロン酸、2−ヒドロキシ酪酸、3−ヒドロキシ酪酸、リンゴ酸、酒石酸、シトラマル酸、クエン酸、イソクエン酸、ロイシン酸、メバロン酸、パントイン酸、リシノール酸、シキミ酸等が挙げられ、これらのうちグルコン酸、クエン酸、乳酸が好ましく、さらにグルコン酸がより好ましい。例えば、グルコン酸亜鉛は急性経口毒性がラットにおいて5000mg/kgを超える値であり、安全性が非常に高く、母乳代替食品として、また亜鉛欠乏症の予防や治療を目的とした保健機能食品として利用されている。 The zinc salt used in the present invention is a zinc salt of a hydroxy acid, and the hydroxy acid is a carboxylic acid having one or more hydroxyl groups. Specific examples include glycolic acid, glyceric acid, gluconic acid, Examples include glucuronic acid, lactic acid, tartronic acid, 2-hydroxybutyric acid, 3-hydroxybutyric acid, malic acid, tartaric acid, citramalic acid, citric acid, isocitric acid, leucine acid, mevalonic acid, pantoic acid, ricinoleic acid, shikimic acid, etc. Of these, gluconic acid, citric acid and lactic acid are preferred, and gluconic acid is more preferred. For example, zinc gluconate has an acute oral toxicity exceeding 5000 mg / kg in rats and is very safe. It is used as a substitute for breast milk and as a health functional food for the purpose of prevention and treatment of zinc deficiency. ing.
本発明に使用する希土類塩としては、スカンジウム塩、イットリウム塩、ランタン塩、セリウム塩、プラセオジム塩、ネオジム塩、サマリウム塩、ユウロピウム塩、ガドリニウム塩、テルビウム塩、ジスプロシウム塩、ホルミウム塩、エルビウム塩、ツリウム塩、イッテルビウム塩、ルテチウム塩が挙げられ、特にランタン塩、セリウム塩、ガドリニウム塩、イッテルビウム塩が好ましく、ランタン塩、セリウム塩がより好ましい。これらの希土類塩は、一般の試薬や工業用原料として市販されているものを使用することができる。 Examples of rare earth salts used in the present invention include scandium salt, yttrium salt, lanthanum salt, cerium salt, praseodymium salt, neodymium salt, samarium salt, europium salt, gadolinium salt, terbium salt, dysprosium salt, holmium salt, erbium salt, thulium. Salts, ytterbium salts, and lutetium salts are exemplified, and lanthanum salts, cerium salts, gadolinium salts, and ytterbium salts are particularly preferable, and lanthanum salts and cerium salts are more preferable. As these rare earth salts, those commercially available as general reagents or industrial raw materials can be used.
塩としては、いずれの対イオンを有する塩でも使用することができ、塩化物塩、硫酸塩、硝酸塩、臭化物塩、ヨウ化物塩、炭酸塩、リン酸塩、有機酸塩、水酸化物等を例示することができる。有機酸塩としては、一価または二価のカルボン酸やヒドロキシ酸の塩が挙げられ、具体的にはヒドロキシ酸として乳酸、グルコン酸、酒石酸、クエン酸、リンゴ酸が例示でき、一価または二価のカルボン酸として酢酸、プロピオン酸、マロン酸、コハク酸、グルタル酸、アジピン酸、アゼライン酸等が例示できる。これらのうち、塩化物塩、ヒドロキシ酸塩が好ましく、さらに塩化物塩、グルコン酸塩、乳酸塩がより好ましい。 As the salt, any salt having any counter ion can be used, such as chloride salt, sulfate salt, nitrate salt, bromide salt, iodide salt, carbonate salt, phosphate salt, organic acid salt, hydroxide, etc. It can be illustrated. Examples of organic acid salts include monovalent or divalent carboxylic acids and salts of hydroxy acids. Specific examples of hydroxy acids include lactic acid, gluconic acid, tartaric acid, citric acid, and malic acid. Examples of the valent carboxylic acid include acetic acid, propionic acid, malonic acid, succinic acid, glutaric acid, adipic acid, and azelaic acid. Of these, chloride salts and hydroxy acid salts are preferable, and chloride salts, gluconates, and lactates are more preferable.
ヒドロキシ酸希土類塩は、一般の試薬や工業用原料として市販されているものを使用することができるが、またヒドロキシ酸と、汎用の無機の希土類塩や希土類酸化物とから水溶液として調製することも可能である。調製のためのこれらのヒドロキシ酸についても、一般に試薬や工業用原料として市販されているものを使用することができる。調製するには、ヒドロキシ酸の水溶液に希土類の酸化物を直接反応させる方法が挙げられる。また塩化物等の無機希土類塩の水溶液にアルカリ金属の水酸化物を反応させて希土類塩の水酸化物をあらかじめ調製し、さらにヒドロキシ酸を水酸化物と反応させて希土類のヒドロキシ酸を調製することで可能である。アルカリ金属の水酸化物としては、例えば水酸化ナトリウム、水酸化カリウム、水酸化リチウム等が挙げられ、水酸化ナトリウムが好ましい。 As the hydroxy acid rare earth salt, those commercially available as general reagents and industrial raw materials can be used, but it can also be prepared as an aqueous solution from hydroxy acid and general-purpose inorganic rare earth salts and rare earth oxides. Is possible. As these hydroxy acids for preparation, those commercially available as reagents and industrial raw materials can be used. The preparation includes a method in which a rare earth oxide is directly reacted with an aqueous solution of hydroxy acid. In addition, a rare earth salt hydroxide is prepared in advance by reacting an alkali metal hydroxide with an aqueous solution of an inorganic rare earth salt such as chloride, and further a hydroxy acid is reacted with the hydroxide to prepare a rare earth hydroxy acid. Is possible. Examples of the alkali metal hydroxide include sodium hydroxide, potassium hydroxide and lithium hydroxide, and sodium hydroxide is preferable.
カチオン系抗菌剤としては、ビス4級ピリジニウム塩またはポリヘキサメチレンビグアナイドが好ましく、これらの中から二種類以上を併用しても差し支えない。ビス4級ピリジニウム塩としては、1,4−ビス(3,3’−(1−デシルピリジニウム)メチルオキシ)ブタンジブロミドが挙げられ、例えばハイジェニア(登録商標、タマ化学工業製)として市販されているものや特開2005−162731や特開2006−001889などの明細書に記載されている方法またはそれらに準じる方法によって製造することにより入手することができる。 As the cationic antibacterial agent, a bis-quaternary pyridinium salt or polyhexamethylene biguanide is preferable, and two or more of these may be used in combination. Examples of the bis-quaternary pyridinium salt include 1,4-bis (3,3 ′-(1-decylpyridinium) methyloxy) butanedibromide, for example, commercially available as Hygenia (registered trademark, manufactured by Tama Chemical Industry). Can be obtained by manufacturing by the methods described in the specifications such as JP-A-2005-162731 and JP-A-2006-001889, or a method analogous thereto.
ポリヘキサメチレンビグアナイドは下記化学式(I)で表される化合物であり、ヘキサメチレン基とビグアナイド基が交互に結合したポリマーであり、式中のnは10〜16の範囲の整数となり、nの異なる化合物が混合されて使用することも可能である。ポリヘキサメチレンビグアナイドの塩としては、塩酸塩、硫酸塩、有機酸塩等、どのような塩も使用できるが、通常は塩酸塩として「PHMB」等の名称で市販されているものを使用することができる。
Polyhexamethylene biguanide is a compound represented by the following chemical formula (I), which is a polymer in which hexamethylene groups and biguanide groups are alternately bonded. In the formula, n is an integer in the range of 10 to 16, and n is different. It is also possible to use a mixture of compounds. As the salt of polyhexamethylene biguanide, any salt such as hydrochloride, sulfate, organic acid salt, etc. can be used. However, the salt sold under the name “PHMB” is usually used as the hydrochloride. Can do.
本発明の、アレルゲン低減化および抗菌組成物におけるヒドロキシ酸亜鉛と希土類塩の配合率は、噴霧用途、あるいは不織布、紙または繊維への加工用途で、ヒドロキシ酸亜鉛については0.01〜9%、好ましくは0.1〜5%、さらに好ましくは0.2〜2%の範囲で使用することができ、希土類塩については0〜10%、好ましくは0.01〜2%、さらに好ましくは0.05〜1%の範囲で使用することができる。本発明の、アレルゲン低減および抗菌組成物におけるカチオン性抗菌剤の配合率については、噴霧用途で0.001%〜1%、好ましくは0.002〜0.5%、さらに好ましくは0.005〜0.1%の範囲で使用することができる。またカチオン性抗菌剤の不織布、紙または繊維への加工用途では、0.001%〜5%、好ましくは0.005〜2%、さらに好ましくは0.01〜1%の範囲で使用することができる。 The compounding ratio of zinc hydroxy acid and rare earth salt in the allergen-reducing and antibacterial composition of the present invention is 0.01 to 9% for zinc hydroxy acid in spraying applications or processing to nonwovens, paper or fibers, Preferably, it can be used in the range of 0.1 to 5%, more preferably 0.2 to 2%. For rare earth salts, 0 to 10%, preferably 0.01 to 2%, and more preferably 0.8%. It can be used in the range of 05 to 1%. About the compounding ratio of the cationic antibacterial agent in the allergen reduction and antibacterial composition of the present invention, 0.001% to 1%, preferably 0.002 to 0.5%, more preferably 0.005 to 0.005 for spraying applications. It can be used in the range of 0.1%. Moreover, in the processing use to the nonwoven fabric of a cationic antibacterial agent, paper, or a fiber, it is 0.001%-5%, Preferably it is 0.005 to 2%, More preferably, it is used in 0.01 to 1% of range. it can.
本発明の、アレルゲン低減化および抗菌組成物が対象とするアレルゲンには、ヤケヒョウヒダニ(Dermatophagoides pteronyssinus)の糞由来のアレルゲン(Der p1)および虫体由来のアレルゲン(Der p2)、コナヒョウヒダニ(Dermatophagoides farinae)の糞由来のアレルゲン(Der f1)および虫体由来のアレルゲン(Der f2)が挙げられる。また植物を由来とするアレルゲンとして、スギ(Cryptomeria japonica)の花粉由来のアレルゲン(Cry j1)を筆頭に、ヒノキ、ブタクサ、ヨモギ、カモガヤ、ハルガヤ等のアレルゲンが挙げられる。その他にも、イヌの毛やフケ由来のアレルゲン(Can f1、Can f2)、ネコの毛やフケ由来のアレルゲン(Fel d1)、ゴキブリ由来のアレルゲン(Bra g1、Bra g2)、カビ由来のアレルゲン(Alt a1)、天然ゴムラテックス由来のアレルゲン等が挙げられる。これらの中でも、ダニ由来のアレルゲンおよびスギ花粉由来のアレルゲンは、特に低減化が必要なアレルゲンとして重要視されている。 Of the present invention, the allergens allergen-reducing and antimicrobial composition is intended, Dermatophagoides pteronyssinus (Dermatophagoides pteronyssinus) feces-derived allergen (Der p1) and parasite-derived allergen (Der p2), D. farinae of (Dermatophagoides farinae) An allergen derived from feces (Der f1) and an allergen derived from worms (Der f2) can be mentioned. Moreover, as an allergen derived from a plant, allergens such as cypress, ragweed, mugwort, camogaya, and hurghaya are mentioned, starting with the allergen (Cry j1) derived from pollen of cedar ( Cryptomeria japonica ). In addition, allergens derived from dog hair and dandruff (Can f1, Can f2), feline hair and dandruff allergens (Fel d1), cockroach-derived allergens (Brag 1, Bra g 2), fungi allergens ( Alt a1), natural rubber latex-derived allergen and the like. Among these, allergens derived from ticks and allergens derived from cedar pollen are regarded as important as allergens that particularly require reduction.
本発明の、アレルゲン低減化および抗菌組成物が対象とする細菌には、黄色ブドウ球菌(Staphylococcus aureus)、大腸菌(Escherichia coli)、緑膿菌(Pseudomonas aeruginosa)等の一般に繁殖する雑菌が挙げられ、MRSAのような耐性菌も対象とする菌として挙げることができる。 Bacteria targeted by the allergen-reducing and antibacterial composition of the present invention include commonly proliferating bacteria such as Staphylococcus aureus , Escherichia coli , and Pseudomonas aeruginosa . Resistant bacteria such as MRSA can also be mentioned as target bacteria.
また本発明の、アレルゲン低減化および抗菌組成物を製剤化する場合、水をベースとした液剤とすることが適しており、ヒドロキシ酸の亜鉛塩および希土類塩を有効成分の合計として0.01〜5%、好ましくは0.1%〜3%、さらに好ましくは0.1〜2%の範囲で含有する。また噴霧剤として使用するときは、噴霧したときの乾燥性を向上させるため、揮発性の有機溶剤を添加することも可能である。このような有機溶剤として特に制限はないが、安全性に問題のない揮発性が高い溶剤としてエタノールが挙げられる。さらに噴霧剤にはその他の成分として、香料、消臭成分等を添加することも可能である。 In addition, when formulating the allergen-reducing and antibacterial composition of the present invention, it is suitable to be a water-based solution, and the zinc salt and rare earth salt of hydroxy acid as a total of 0.01 to 5%, preferably 0.1% to 3%, more preferably 0.1 to 2%. In addition, when used as a spray, it is possible to add a volatile organic solvent in order to improve the drying property when sprayed. Although there is no restriction | limiting in particular as such an organic solvent, Ethanol is mentioned as a highly volatile solvent which does not have a safety problem. Furthermore, a fragrance | flavor, a deodorizing component, etc. can also be added to a spray agent as other components.
上記の噴霧剤は、室内等の居住空間、車や電車等の乗り物内の空間に対して適用することができ、空間内に付着あるいは浮遊によって存在する、ダニや花粉等の種々のアレルゲンを低減することが可能となる。 The above-mentioned spray can be applied to living spaces such as indoors, spaces in vehicles such as cars and trains, and reduces various allergens such as mites and pollen that are present by adhering or floating in the space. It becomes possible to do.
製剤を行なう上で、安定性の向上や、香料等の油性成分の溶解等の目的のために界面活性剤を添加することが可能である。界面活性剤は特に限定されず、非イオン性界面活性剤、アニオン性界面活性剤、カチオン性界面活性剤、両性界面活性剤を挙げることができる。非イオン性界面活性剤の種類は特に限定されるものではないが、例えばポリオキシアルキレンアルキルフェニルエーテル、ポリオキシアルキレンスチリルフェニルエーテル、ポリオキシアルキレンアルキルエーテル、ポリオキシアルキレンアルケニルエーテル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル等が挙げられる。アニオン性界面活性剤にはアルキルベンゼンスルホネート、ポリオキシエチレンアルキルフェニルエーテルサルフェート、ジアルキルスルホサクシネート等が挙げられる。カチオン性界面活性剤では脂肪族アミン塩およびその4級アンモニウム塩等が挙げられ、両イオン性界面活性剤ではベタイン型界面活性剤、アミノカルボン酸塩等が挙げられる。また、これらの非イオン性界面活性剤、アニオン性界面活性剤、カチオン性界面活性剤および両イオン性界面活性剤は一種を単独に用いても二種以上を併用してもよい。 In carrying out the preparation, a surfactant can be added for the purpose of improving stability and dissolving oily components such as fragrances. The surfactant is not particularly limited, and examples thereof include a nonionic surfactant, an anionic surfactant, a cationic surfactant, and an amphoteric surfactant. The type of the nonionic surfactant is not particularly limited. For example, polyoxyalkylene alkyl phenyl ether, polyoxyalkylene styryl phenyl ether, polyoxyalkylene alkyl ether, polyoxyalkylene alkenyl ether, sorbitan fatty acid ester, polyoxyalkylene alkyl ether, Examples thereof include oxyethylene sorbitan fatty acid esters. Examples of the anionic surfactant include alkyl benzene sulfonate, polyoxyethylene alkyl phenyl ether sulfate, and dialkyl sulfosuccinate. Cationic surfactants include aliphatic amine salts and quaternary ammonium salts thereof, and amphoteric surfactants include betaine surfactants and aminocarboxylates. These nonionic surfactants, anionic surfactants, cationic surfactants and amphoteric surfactants may be used alone or in combination of two or more.
本発明のアレルゲン低減化および抗菌組成物には、物性を損なわない範囲で、公知となっている他のアレルゲン低減化成分をさらに添加することも可能である。アレルゲン低減化成分としては、ジヒドロキシ安息香酸や2,4,6−トリヒドロキシ安息香酸等のヒドロキシ安息香酸系化合物またはその塩、パラヒドロキシポリスチレンやポリスチレンスルホン酸塩等のポリスチレン系化合物、柿渋等の天然抽出物、カルシウム塩やストロンチウム塩等の無機塩系化合物が挙げられる。 The allergen-reducing and antibacterial composition of the present invention can be further added with other known allergen-reducing components as long as the physical properties are not impaired. Examples of allergen-reducing components include hydroxybenzoic acid compounds such as dihydroxybenzoic acid and 2,4,6-trihydroxybenzoic acid or salts thereof, polystyrene compounds such as parahydroxypolystyrene and polystyrenesulfonate, Examples include extracts, inorganic salt compounds such as calcium salts and strontium salts.
本発明のアレルゲン低減化および抗菌組成物は、屋内塵性ダニのアレルゲン除去を目的に使用する場合、殺ダニ剤と同時に加工することにより、そのアレルゲン低減化効果をさらに持続させることも可能である。使用する殺ダニ剤は、屋内塵性ダニに対して致死効果や忌避効果のあるものであれば特に限定はなく、例えば、ベンジルアルコール、ベンジルベンゾエート、サリチル酸フェニル、シンナムアルデヒド、ヒソップ油、ニンジン種子油等を用いることができ、また天然ピレトリン、フェノトリン、ペルメトリン等のピレスロイド系化合物、フェニトロチオン、マラチオン、フェンチオン、ダイアジノン等の有機リン系化合物、ジコホル、クロルベンジレート、ヘキシチアゾクス、テブフェンピラド、ピリダベン、アミドフルメト等を用いることができる。 When the allergen-reducing and antibacterial composition of the present invention is used for the purpose of removing allergens from indoor dust mites, the allergen-reducing effect can be further maintained by processing simultaneously with an acaricide. . The acaricide used is not particularly limited as long as it has a lethal and repellent effect on indoor dust mites. For example, benzyl alcohol, benzyl benzoate, phenyl salicylate, cinnamaldehyde, hyssop oil, carrot seed oil In addition, pyrethroid compounds such as natural pyrethrin, phenothrin, and permethrin, organophosphorus compounds such as fenitrothion, malathion, fenthion, and diazinon, dicofol, chlorbenzilate, hexythiazox, tebufenpyrad, pyridaben, and amidoflumet are used. be able to.
香料としては、例えば、アセト酢酸エチル、アニスアルデヒド、アントラニル酸メチル、アネトール、エチルバニリン、オイゲノール、ゲラニオール、酢酸ベンジル、サリチル酸メチル、シトラール、シトロネラール、シトロネロール、シネオール、n−デシルアルコール、α−テルピネオール、バニリン、ピネン、ベンジルサクシネート、メチルオイゲノール、リモネン、リナロール等が挙げられる。また天然精油系香料としては、オレンジ油、桂皮油、シソ油、スペアミント油、セージ油、タイム油、ティーツリー油、ナツメグ油、バジル油、ピメント油、ペパーミント油、ラベンダー油、レモン油、ローズマリー油、ユーカリ油などが挙げられる。 Examples of the fragrance include ethyl acetoacetate, anisaldehyde, methyl anthranilate, anethole, ethyl vanillin, eugenol, geraniol, benzyl acetate, methyl salicylate, citral, citronellal, citronellol, cineol, n-decyl alcohol, α-terpineol, vanillin , Pinene, benzyl succinate, methyl eugenol, limonene, linalool and the like. Natural essential oils such as orange oil, cinnamon oil, perilla oil, spearmint oil, sage oil, thyme oil, tea tree oil, nutmeg oil, basil oil, pimento oil, peppermint oil, lavender oil, lemon oil, rosemary Oil, eucalyptus oil and the like.
本発明のアレルゲン低減化および抗菌組成物の製剤化に際しては、前述の界面活性剤、防ダニ剤の他に、必要に応じてキレート剤、防錆剤、スケール防止剤、消泡剤、帯電防止剤、樹脂バインダー、増粘剤、柔軟加工剤等を添加することも可能である。 In the allergen reduction and formulation of the antibacterial composition of the present invention, in addition to the aforementioned surfactant and anti-mite agent, chelating agent, anti-rust agent, scale inhibitor, antifoaming agent, antistatic agent as necessary It is also possible to add an agent, a resin binder, a thickener, a softening agent, and the like.
本発明を実施例、試験例により更に詳しく説明するが、本発明がこれらによって限定されるものではない。なお、下記に示す%はすべて重量%である。 The present invention will be described in more detail with reference to examples and test examples, but the present invention is not limited thereto. In addition, all% shown below are weight%.
実施例および比較例の調製のため、原料として以下の試薬等を使用した。 For the preparation of Examples and Comparative Examples, the following reagents and the like were used as raw materials.
グルコン酸亜鉛三水和物(ヘルシャスZn(登録商標)、扶桑化学工業株式会社製)
塩化ランタン七水和物(和光純薬工業株式会社製)
酸化ランタン(和光純薬工業株式会社製)
90%乳酸(株式会社武蔵野化学研究所製)
プロクセルIB(PHMB20%溶液、登録商標、ロンザジャパン株式会社)
ハイジェニアS−100(タマ化学株式会社製)
Zinc gluconate trihydrate (Helsius Zn (registered trademark), manufactured by Fuso Chemical Industry Co., Ltd.)
Lanthanum chloride heptahydrate (Wako Pure Chemical Industries, Ltd.)
Lanthanum oxide (manufactured by Wako Pure Chemical Industries, Ltd.)
90% lactic acid (Musashino Chemical Laboratory Co., Ltd.)
Proxel IB (PHMB 20% solution, registered trademark, Lonza Japan KK)
Hygenia S-100 (manufactured by Tama Chemical Co., Ltd.)
乳酸ランタン水溶液の調製
玉入れ冷却管を取り付けた100mL容量の三角フラスコに、90%乳酸溶液4.5gとイオン交換水69.0gを混合し、さらに酸化ランタン1.2gを添加した。湯浴中で75℃に加温して撹拌を3時間継続し、酸化ランタンを溶解させた。放冷し、乳酸ランタン水溶液を得た。
Preparation of Lanthanum Lactate Aqueous Solution To a 100 mL Erlenmeyer flask equipped with a ball cooling tube, 4.5 g of 90% lactic acid solution and 69.0 g of ion-exchanged water were mixed, and 1.2 g of lanthanum oxide was further added. The mixture was heated to 75 ° C. in a hot water bath and stirring was continued for 3 hours to dissolve lanthanum oxide. The mixture was allowed to cool to obtain an aqueous lanthanum lactate solution.
実施例1〜5、比較例1〜6を表1、表2に示す配合で、混合、撹拌、溶解することにより調製した。 Examples 1 to 5 and Comparative Examples 1 to 6 were prepared by mixing, stirring and dissolving in the formulations shown in Tables 1 and 2.
[試験例1]殺菌力試験
細菌に対する抗菌力の評価を行うため、黄色ブドウ球菌(NBRC12732)を用いて殺菌力試験を行った。TGC液体培地にて前培養した黄色ブドウ球菌の菌株を滅菌水に懸濁し、生菌数が約106CFU/mLとなるように調整した菌液を5mLずつ試験管に分注し、これらの菌液に実施例1〜5、比較例1〜6をそれぞれ菌液に対して所定の濃度(0.5%または2%)となるように添加した。添加後から所定の時間(30分および1時間)が経過した後に各試験管から100μLを採取してシャーレに採り、培地15mLを加えて均一に溶解した。37℃にて3日間培養し、発生したコロニー数をカウントすることにより生菌数を測定した。ブランクとしては滅菌水を用いた。結果を表3に示す。
[Test Example 1] Bactericidal activity test In order to evaluate the antibacterial activity against bacteria, a bactericidal activity test was performed using Staphylococcus aureus (NBRC12732). A strain of Staphylococcus aureus pre-cultured in a TGC liquid medium is suspended in sterilized water, and 5 mL of the bacterial solution adjusted so that the viable cell count is about 10 6 CFU / mL is dispensed into test tubes. Examples 1 to 5 and Comparative Examples 1 to 6 were added to the bacterial solution so as to have a predetermined concentration (0.5% or 2%) with respect to the bacterial solution. After a predetermined time (30 minutes and 1 hour) had elapsed after the addition, 100 μL was collected from each test tube and placed in a petri dish, and 15 mL of medium was added to dissolve uniformly. After culturing at 37 ° C. for 3 days, the number of viable bacteria was measured by counting the number of colonies generated. Sterile water was used as a blank. The results are shown in Table 3.
[試験例2]ダニアレルゲンの低減化効果の測定
ダニアレルゲンDer f2を含有する、タンパク質量として約900ng/1mL{リン酸緩衝液(pH7.2)}のアレルゲン液1mLに対し、実施例1〜5、比較例1〜6を、それぞれ150μLまたは500μLを反応させた。これら試料について Der f2酵素免疫測定法(ELISA)のサンドイッチ法にてダニアレルゲン低減化効果の測定を行った。まず、リン酸緩衝液(pH7.4)で2μg/mLに希釈した抗Der f2 モノクローナル抗体15E11を、F16 MAXISORP NUNC−IMMUNO MODULEプレート(NUNC社製)の1ウェルあたり100μLずつ添加し、4℃にて3日以上感作させた。感作後、液を捨て、ブロッキング試薬{1重量%牛血清アルブミン+リン酸緩衝液(pH7.2)}を1ウェルあたり200μLずつ添加し、37℃、60分間反応させた。反応後、リン酸緩衝液(pH7.2)にてプレートを洗浄した。
[Test Example 2] Measurement of mite allergen reducing effect Example 1 to 1 mL of allergen solution containing mite allergen Der f2 and about 900 ng / 1 mL {phosphate buffer (pH 7.2)} of protein. 5. Comparative Examples 1 to 6 were reacted with 150 μL or 500 μL, respectively. About these samples, the mite allergen reduction effect was measured by the sandwich method of Der f2 enzyme immunoassay (ELISA). First, anti-Der f2 monoclonal antibody 15E11 diluted to 2 μg / mL with phosphate buffer (pH 7.4) was added in an amount of 100 μL per well of an F16 MAXISORP NUNC-IMMUNO MODULE plate (manufactured by NUNC), and then added to 4 ° C. Sensitized for more than 3 days. After sensitization, the solution was discarded, and 200 μL of a blocking reagent {1 wt% bovine serum albumin + phosphate buffer (pH 7.2)} was added per well and reacted at 37 ° C. for 60 minutes. After the reaction, the plate was washed with a phosphate buffer (pH 7.2).
次に、ダニアレルゲンと上記組成物を反応させて得られた抽出液を1ウェルあたり100μLずつ滴下し、37℃、60分間反応させた。反応後、リン酸緩衝液(pH7.2)にてプレートを洗浄した。ペルオキシダーゼ標識した抗Der f2モノクローナル抗体をリン酸緩衝液{pH7.2、1重量%牛血清アルブミンおよび0.05重量%ポリオキシエチレン(20)ソルビタンモノラウレート含有}で200μg/mLに溶解し、それをリン酸緩衝液(pH7.2、1重量%牛血清アルブミンおよび0.05重量%ポリオキシエチレン(20)ソルビタンモノラウレート含有)で1200倍希釈した液を、1ウェルあたり100μLずつ添加した。37℃、60分間反応させた後、リン酸緩衝液(pH7.2)でプレートを洗浄した。0.1mol/Lリン酸緩衝液(pH6.2)6.5mLにオルト−フェニレンジアミンジヒドロクロライド(13mg Tablet、和光純薬工業株式会社製)一錠と30%過酸化水素水6.5μLを加えたものを1ウェルあたり100μLずつ添加し、37℃、3分間反応させた。その後直ちに、1mol/L H2SO4を50μLずつ入れて反応を停止させ、マイクロプレート用分光光度計(テカンジャパン株式会社製)で吸光度(OD490nm)を測定した。結果を表4に示した。 Next, 100 μL of the extract obtained by reacting the mite allergen and the above composition was added dropwise per well and reacted at 37 ° C. for 60 minutes. After the reaction, the plate was washed with a phosphate buffer (pH 7.2). Peroxidase-labeled anti-Der f2 monoclonal antibody was dissolved in phosphate buffer {pH 7.2, containing 1% by weight bovine serum albumin and 0.05% by weight polyoxyethylene (20) sorbitan monolaurate} at 200 μg / mL, A solution obtained by diluting it with phosphate buffer (pH 7.2, containing 1% by weight bovine serum albumin and 0.05% by weight polyoxyethylene (20) sorbitan monolaurate) 1200 times was added at 100 μL per well. . After reacting at 37 ° C. for 60 minutes, the plate was washed with a phosphate buffer (pH 7.2). To 6.5 mL of 0.1 mol / L phosphate buffer (pH 6.2), add 1 tablet of ortho-phenylenediamine dihydrochloride (13 mg Table, manufactured by Wako Pure Chemical Industries, Ltd.) and 6.5 μL of 30% hydrogen peroxide solution. 100 μL was added per well and reacted at 37 ° C. for 3 minutes. Immediately thereafter, 50 μL of 1 mol / L H 2 SO 4 was added to stop the reaction, and the absorbance (OD 490 nm) was measured with a spectrophotometer for microplate (manufactured by Tecan Japan Co., Ltd.). The results are shown in Table 4.
[試験例3]スギ花粉アレルゲンの低減化効果の測定
スギ花粉アレルゲンCry j1として約12.5ng/1mL{リン酸緩衝液(pH7.2)}のアレルゲン液1mLに対し、実施例1〜5、比較例1〜6を、それぞれ150μLまたは500μLを反応させた。これら試料についてCry j1酵素免疫測定法(ELISA)のサンドイッチ法にてスギ花粉アレルゲン低減化効果の測定を行った。まず、リン酸緩衝液(pH7.4、0.1重量%NaN3含有)で2μg/mLに希釈したCry j1 モノクローナル抗体013を、F16 MAXISORP NUNC−IMMUNO MODULEプレート(NUNC社製)の1ウェルあたり100μLずつ添加し、4℃にて1日以上感作させた。感作後、液を捨て、ブロッキング試薬{1重量%牛血清アルブミン+リン酸緩衝液(pH7.2、0.1重量%NaN3含有)}を1ウェルあたり200μLずつ添加し、37℃、60分間反応させた。反応後、リン酸緩衝液{pH7.2、0.1重量%ポリオキシエチレン(20)ソルビタンモノラウレート含有}にてプレートを洗浄した。
[Test Example 3] Measurement of reduction effect of cedar pollen allergen Example 1-5 with respect to 1 mL of allergen solution of about 12.5 ng / 1 mL {phosphate buffer (pH 7.2)} as cedar pollen allergen Cry j1. In Comparative Examples 1 to 6, 150 μL or 500 μL was reacted. These samples were measured for the effect of reducing cedar pollen allergen by the sandwich method of Cry j1 enzyme immunoassay (ELISA). First, Cry j1 monoclonal antibody 013 diluted to 2 μg / mL with phosphate buffer (pH 7.4, containing 0.1 wt% NaN 3 ) was added per well of F16 MAXISORP NUNC-IMMUNO MODULE plate (manufactured by NUNC). 100 μL each was added and sensitized at 4 ° C. for 1 day or longer. After sensitization, the solution was discarded, and a blocking reagent {1% by weight bovine serum albumin + phosphate buffer (pH 7.2, containing 0.1% by weight NaN 3 )} was added in an amount of 200 μL per well. Reacted for 1 minute. After the reaction, the plate was washed with a phosphate buffer (pH 7.2, containing 0.1 wt% polyoxyethylene (20) sorbitan monolaurate).
次に、スギ花粉アレルゲンと上記組成物を反応させて得られた抽出液試料を1ウェルあたり100μLずつ滴下し、37℃、60分間反応させた。反応後、リン酸緩衝液{pH7.2、0.1重量%ポリオキシエチレン(20)ソルビタンモノラウレート含有}にてプレートを洗浄した。ペルオキシダーゼ標識したCry j1モノクローナル抗体053を蒸留水で200μg/mLに溶解し、それをリン酸緩衝液{pH7.2、1重量%牛血清アルブミンおよび0.1重量%ポリオキシエチレン(20)ソルビタンモノラウレート含有}で1200倍希釈した液を、1ウェルあたり100μLずつ添加した。37℃、60分間反応させた後、リン酸緩衝液{pH7.2、0.1重量%ポリオキシエチレン(20)ソルビタンモノラウレート含有}でプレートを洗浄した。0.1mol/Lリン酸緩衝液(pH6.2)13mLにオルト−フェニレンジアミンジヒドロクロライド(SIGMA CHEMICAL CO.製:26mg Tablet)と過酸化水素水13μLを加えたものを1ウェルあたり100μLずつ添加し、37℃、5分間反応させた。その後直ちに、2mol/L H2SO4を50μLずつ入れて反応を停止させ、マイクロプレート用分光光度計(テカンジャパン株式会社製)で吸光度(OD490nm)を測定した。結果を表5に示した。 Next, 100 μL of the extract sample obtained by reacting the cedar pollen allergen and the above composition was added dropwise per well and reacted at 37 ° C. for 60 minutes. After the reaction, the plate was washed with a phosphate buffer (pH 7.2, containing 0.1 wt% polyoxyethylene (20) sorbitan monolaurate). Peroxidase-labeled Cry j1 monoclonal antibody 053 was dissolved in distilled water to 200 μg / mL, and then dissolved in phosphate buffer {pH 7.2, 1 wt% bovine serum albumin and 0.1 wt% polyoxyethylene (20) sorbitan mono A solution diluted 1200 times with laurate contained} was added at 100 μL per well. After reacting at 37 ° C. for 60 minutes, the plate was washed with a phosphate buffer (pH 7.2, containing 0.1 wt% polyoxyethylene (20) sorbitan monolaurate). Add 100 μL per well of 13 mol of 0.1 mol / L phosphate buffer (pH 6.2) plus ortho-phenylenediamine dihydrochloride (manufactured by SIGMA CHEMICAL CO .: 26 mg Table) and 13 μL of hydrogen peroxide. And allowed to react at 37 ° C. for 5 minutes. Immediately thereafter, 50 μL of 2 mol / L H 2 SO 4 was added to stop the reaction, and the absorbance (OD 490 nm) was measured with a spectrophotometer for microplate (Tecan Japan Co., Ltd.). The results are shown in Table 5.
本発明の、ヒドロキシ酸亜鉛およびカチオン性抗菌剤を含有するアレルゲン低減化および抗菌組成物、さらにはヒドロキシ酸亜鉛、希土類塩およびカチオン性抗菌剤を含有するアレルゲン低減化および抗菌組成物を使用することにより、着色の問題を起こすことなくダニや花粉等のアレルゲンのアレルゲン性を低減化させることができ、また雑菌の繁殖を抑制することができる。
Use of the allergen-reducing and antibacterial composition containing zinc hydroxy acid and a cationic antibacterial agent of the present invention, and further an allergen reducing and antibacterial composition containing zinc hydroxy acid, a rare earth salt and a cationic antibacterial agent Thus, the allergenicity of allergens such as mites and pollen can be reduced without causing coloring problems, and the propagation of germs can be suppressed.
Claims (6)
The allergen-reducing and antibacterial composition according to any one of claims 1 to 5, wherein the use is for spraying.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015183748 | 2015-09-17 | ||
JP2015183748 | 2015-09-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017057194A true JP2017057194A (en) | 2017-03-23 |
JP7007540B2 JP7007540B2 (en) | 2022-02-10 |
Family
ID=58389626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016163991A Active JP7007540B2 (en) | 2015-09-17 | 2016-08-24 | Allergen reduction and antibacterial composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7007540B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018123210A (en) * | 2017-01-31 | 2018-08-09 | 白元アース株式会社 | Allergen reducing antimicrobial composition |
WO2018190248A1 (en) * | 2017-04-10 | 2018-10-18 | 住化エンバイロメンタルサイエンス株式会社 | Allergen-reducing composition |
CN111154753A (en) * | 2020-03-09 | 2020-05-15 | 重庆市大足区人民医院 | Magnetic bead method bacterial nucleic acid extracting solution |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09510976A (en) * | 1994-03-28 | 1997-11-04 | ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク | Composition for inactivating stimulants in a liquid |
JP2001322937A (en) * | 2000-03-08 | 2001-11-20 | Shinto Fine Co Ltd | Antiallergenic composition and method of inactivation for allergen |
JP2006001889A (en) * | 2004-06-18 | 2006-01-05 | Hiroki Koma | Bactericidal pyridine compound |
CN101176468A (en) * | 2007-11-28 | 2008-05-14 | 暨南大学 | Inorganic complex antimicrobials containing zincium-rare earth as well as preparation method and application thereof |
JP2008297335A (en) * | 2007-05-29 | 2008-12-11 | Sumika Enviro-Science Co Ltd | Antiallergenic composition, and method for reducing allergen |
CN101543228A (en) * | 2009-04-30 | 2009-09-30 | 广东迪美生物技术有限公司 | Copper-rare earth compound antimicrobial agent and preparation method and application thereof |
JP2010215598A (en) * | 2009-03-19 | 2010-09-30 | Diversey Co Ltd | Virucidal agent composition for calicivirus and method of application thereof |
CN102138569A (en) * | 2010-01-28 | 2011-08-03 | 广东炜林纳功能材料有限公司 | Rare-earth composite antibacterial agent and application thereof |
JP2011231431A (en) * | 2010-04-28 | 2011-11-17 | Dainippon Jochugiku Co Ltd | Antimicrobial-antiviral treatment method for fiber product |
JP2012233058A (en) * | 2011-04-28 | 2012-11-29 | Ueno Fine Chem Ind Ltd | Sterilizing detergent composition, and sterilizing cleaning method |
JP2014019669A (en) * | 2012-07-19 | 2014-02-03 | Sumika Enviro-Science Co Ltd | Antimicrobial composition for aqueous composition containing reductant |
WO2015093519A1 (en) * | 2013-12-20 | 2015-06-25 | 日本曹達株式会社 | Disinfectant composition |
-
2016
- 2016-08-24 JP JP2016163991A patent/JP7007540B2/en active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09510976A (en) * | 1994-03-28 | 1997-11-04 | ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク | Composition for inactivating stimulants in a liquid |
JP2001322937A (en) * | 2000-03-08 | 2001-11-20 | Shinto Fine Co Ltd | Antiallergenic composition and method of inactivation for allergen |
JP2006001889A (en) * | 2004-06-18 | 2006-01-05 | Hiroki Koma | Bactericidal pyridine compound |
JP2008297335A (en) * | 2007-05-29 | 2008-12-11 | Sumika Enviro-Science Co Ltd | Antiallergenic composition, and method for reducing allergen |
CN101176468A (en) * | 2007-11-28 | 2008-05-14 | 暨南大学 | Inorganic complex antimicrobials containing zincium-rare earth as well as preparation method and application thereof |
JP2010215598A (en) * | 2009-03-19 | 2010-09-30 | Diversey Co Ltd | Virucidal agent composition for calicivirus and method of application thereof |
CN101543228A (en) * | 2009-04-30 | 2009-09-30 | 广东迪美生物技术有限公司 | Copper-rare earth compound antimicrobial agent and preparation method and application thereof |
CN102138569A (en) * | 2010-01-28 | 2011-08-03 | 广东炜林纳功能材料有限公司 | Rare-earth composite antibacterial agent and application thereof |
JP2011231431A (en) * | 2010-04-28 | 2011-11-17 | Dainippon Jochugiku Co Ltd | Antimicrobial-antiviral treatment method for fiber product |
JP2012233058A (en) * | 2011-04-28 | 2012-11-29 | Ueno Fine Chem Ind Ltd | Sterilizing detergent composition, and sterilizing cleaning method |
JP2014019669A (en) * | 2012-07-19 | 2014-02-03 | Sumika Enviro-Science Co Ltd | Antimicrobial composition for aqueous composition containing reductant |
WO2015093519A1 (en) * | 2013-12-20 | 2015-06-25 | 日本曹達株式会社 | Disinfectant composition |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018123210A (en) * | 2017-01-31 | 2018-08-09 | 白元アース株式会社 | Allergen reducing antimicrobial composition |
WO2018190248A1 (en) * | 2017-04-10 | 2018-10-18 | 住化エンバイロメンタルサイエンス株式会社 | Allergen-reducing composition |
CN111154753A (en) * | 2020-03-09 | 2020-05-15 | 重庆市大足区人民医院 | Magnetic bead method bacterial nucleic acid extracting solution |
Also Published As
Publication number | Publication date |
---|---|
JP7007540B2 (en) | 2022-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6906257B2 (en) | Allergen reduction composition and allergen reduction method | |
JP5850484B2 (en) | Anti-allergen composition | |
JP5959041B2 (en) | Method for providing allergen reduction function | |
JP7007540B2 (en) | Allergen reduction and antibacterial composition | |
JP2002326944A (en) | Anti-allergen composition and method for deactivating allergen | |
JP4968899B2 (en) | Anti-allergen composition | |
JP6764783B2 (en) | Allergen reduction composition, spraying agent and surface processing agent containing it, allergen reduction method | |
JP6735547B2 (en) | Allergen-reducing composition for fibers | |
JP2011256283A (en) | Antiallergenic composition | |
JP2010116450A (en) | Antiallergenic composition | |
JP5114692B2 (en) | Anti-allergen composition and method for reducing allergen | |
JP7048960B2 (en) | Allergen reduction composition | |
JP2018012799A (en) | Allergen reducing composition | |
JP5467636B2 (en) | Anti-allergen composition | |
JP2020164604A (en) | Allergen-reducing composition | |
JP7255931B2 (en) | Allergen-reducing composition | |
JP6969776B2 (en) | Allergen reduction composition | |
WO2018190248A1 (en) | Allergen-reducing composition | |
JP6904521B2 (en) | Allergen reduction composition | |
JP7224022B2 (en) | antiviral composition | |
JP5927625B2 (en) | Anti-allergen composition | |
JP2014189627A (en) | Allergen-reducing composition | |
JP2015178582A (en) | allergen-reducing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190823 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200721 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200818 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20201015 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201214 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210601 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210730 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211214 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211214 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7007540 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |